A new browse by facet category has been added to MAESTrO New Zealand - PTAC comment on budget impact. The response categories for this new facet are:

• Cost neutral – the PTAC recommended that the health care technology should be listed in the New Zealand Pharmaceutical Schedule and that it should be at least cost neutral to the budget
• Capped budget – the PTAC recommended that the budget for the health care technology (or class of technologies) be capped for the given indication/patient population
• No comment – the PTAC recommended the listing of the health care technology in the New Zealand Pharmaceutical Schedule but made no comment on the likely budget impact of the listing in the minutes
• Not applicable – the health care technology was not recommended by the PTAC
• Not available – PTAC minutes are not available; it is unclear if the PTAC reviewed the funding application for the health care technology

The Help section has also been updated.